A unique influenza vaccine candidate that’s inhaled and based on technology developed by University of Wisconsin–Madison researchers is safe and could bolster protection against seasonal and pandemic influenza....
Diversity in clinical research has become a hot topic in recent years, with heightened attention leading to dramatic changes in the regulatory framework, including U.S. legislation broadening the scope of diversity consideration in clinical trials....
As a Black psychologist of Barbadian descent, Jackman knew she was looking for a therapist of color who had experience working with couples. The search, however, proved to be more challenging than she expected....
The Carbone Cancer Center held its 11th annual 'Roll & Stroll' event on Sunday to help support pancreatic cancer patients and research....
The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the Neffy epinephrine nasal spray. Neffy is a non-needle-based epinephrine treatment for anaphylaxis and other allergic reactions...
After decades of disappointments, a potential breakthrough treatment for Alzheimer’s disease is sparking a new symptom in researchers, clinicians, caregivers and families: hope....
Recently published results from a clinical trial showed that for critically ill adults needing tracheal intubation for emergency airway support, the method health care providers choose to use for providing supplemental oxygen before the intubation procedure affects the patient’s risk of hypoxemia, or potentially life-threatening...
By prioritizing quality in clinical research, organizations aspire to enhance their competitive edge, reduce costs through efficient processes, and foster a culture of excellence....
Cystic fibrosis is a hereditary condition, occurring in approximately one in 4,000 births. It causes normally slippery fluids in lungs and digestive system organs to become thick and sticky, resulting in lung and digestive impairment, risk of severe lung infections, malnutrition, and death....
The tests offer a fast and easy way for physicians to learn whether a patient with symptoms of cognitive decline also has the brain changes associated with Alzheimer’s. Evidence of those brain changes is required before doctors can prescribe one of two recently approved drugs...
